SHORT REPORT
Carcinoembryonic antigen (CEA) testing in colorectal cancer follow up: what do patients think?
1 Edinburgh Cancer Centre, Western General Hospital, Edinburgh, UK
2 Beatson West of Scotland Cancer Centre, Glasgow, UK
Correspondence to:
Correspondence to:
Dr Nicola Steele
The Beatson West of Scotland Cancer Centre, 1053 Great Western Road, Glasgow G12 0YN, UK; nicola.steele{at}northglasgow.scot.nhs.uk
The carcinoembryonic antigen (CEA) blood test is included in most colorectal cancer follow up protocols, despite little clear evidence for its cost-effectiveness and survival benefit. In this study, patients views were sought on the use of the CEA blood test in their follow up. Strong associations were found between the age of a patients children and their concern about cancer recurrence and between concern about recurrence and anxiety about CEA test results (p<0.0001). Many patients expressed a desire for prognostic information, however uncertain or poor. Patients views should be sought when designing colorectal cancer follow up protocols to ensure their needs are adequately addressed.
Keywords: colorectal cancer; follow up; questionnaire; carcinoembryonic antigen
![]()
CiteULike
Complore
Connotea
Del.icio.us
Digg
Reddit
Technorati What's this?
Register for free content
The full back archive is now available for all BMJ Journals. Institutional subscribers may access the entire archive as part of their subscription. Personal subscribers will also have access to all content when logged in. Non-subscribers who register have free access to all articles published before 2006 right back to volume 1 issue 1. Register here to access the free archive of all BMJ Journals.
Don't forget to sign up for content alerts so you keep up to date with all the articles as they are published.
